Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* A primary diagnosis of MDD~* Depressive symptoms for at least 30 days before the screening visit.~Exclusion Criteria:~* Treatment with DVS SR at any time in the past.~* Known hypersensitivity to venlafaxine~* Significant risk of suicide based on clinical judgment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).